Institutional investors purchased a net $16.1 million shares of TXMD during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 47.39% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RA CAPITAL MANAGEMENT LLC Bought 5.3 Million shares of TherapeuticsMD Inc
GILDER, GAGNON, HOWE & CO. LLC Bought 2.8 Million shares of TherapeuticsMD Inc
WELLINGTON MANAGEMENT CO. LLP Bought 2.2 Million shares of TherapeuticsMD Inc